Title : Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities.

Pub. Date : 2022 Feb 21

PMID : 35209221






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Copper oxide nanoparticles (CuO NPs) were synthesized through the coprecipitation method and used as nanocarriers for etoricoxib (selective COX-2 inhibitor drug) and montelukast (leukotriene product inhibitor drug) in combination therapy. Etoricoxib cytochrome c oxidase II, mitochondrial Mus musculus